Logo

Mission Accomplished: Hycor Becomes Subsidiary of Stratagene

Jun 03, 2004

NEW YORK, June 3 (GenomeWeb News) - Better late than never. Almost a year after announcing their intention to merge, Hycor Biomedical and Stratagene said today that the deal is done.

 

As a result of the merger, which was delayed twice, Hycor will become a wholly owned subsidiary of La Jolla-based Stratagene and will continue to operate at its current location in Garden Grove, Calif. 

Breaking News
The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.